Document:

exv4w3

Exhibit 4.3

Execution Version

VOTING AGREEMENT

 

 

TABLE OF CONTENTS

	 	 	 	 	 
	 	 	PAGE	 
	1. Voting Provisions Regarding Board of Directors
	 	 	1	 
	 
	 	 	 	 
	1.1 Size of the Board
	 	 	1	 
	1.2 Board Composition
	 	 	2	 
	1.3 Failure to Designate a Board Member
	 	 	3	 
	1.4 Removal of Board Members
	 	 	3	 
	1.5 No Liability for Election of Recommended Directors
	 	 	3	 
	 
	 	 	 	 
	2. Vote to Increase Authorized Common Stock
	 	 	3	 
	 
	 	 	 	 
	3. Drag-Along Right
	 	 	3	 
	 
	 	 	 	 
	3.1 Definitions
	 	 	3	 
	3.2 Actions to be Taken
	 	 	4	 
	3.3 Exceptions
	 	 	4	 
	 
	 	 	 	 
	4. Remedies
	 	 	5	 
	 
	 	 	 	 
	4.1 Covenants of the Company
	 	 	5	 
	4.2 Specific Enforcement
	 	 	5	 
	4.3 Remedies Cumulative
	 	 	5	 
	 
	5. Term
	 	 	5	 
	 
	 	 	 	 
	6. Miscellaneous
	 	 	6	 
	 
	 	 	 	 
	6.1 Additional Parties
	 	 	6	 
	6.2 Transfers
	 	 	6	 
	6.3 Successors and Assigns
	 	 	6	 
	6.4 Governing Law
	 	 	6	 
	6.5 Counterparts
	 	 	7	 
	6.6 Titles and Subtitles
	 	 	7	 
	6.7 Notices
	 	 	7	 
	6.8 Consent Required to Amend, Terminate or Waive
	 	 	7	 
	6.9 Delays or Omissions
	 	 	8	 
	6.10 Severability
	 	 	8	 
	6.11 Entire Agreement
	 	 	8	 
	6.12 Legend on Share Certificates
	 	 	8	 
	6.13 Stock Splits, Stock Dividends, etc
	 	 	9	 
	6.14 Manner of Voting
	 	 	9	 
	6.15 Further Assurances
	 	 	9	 
	6.16 Dispute Resolution
	 	 	9	 
	6.17 Costs of Enforcement
	 	 	9	 
	6.18 Aggregation of Stock
	 	 	9	 
	6.19 Spousal Consent
	 	 	9	 
	Schedule A  —  Investors
	 	 	 	 
	Schedule B  —  Key Common Holders
	 	 	 	 
	Exhibit A    —  Adoption Agreement
	 	 	 	 
	Exhibit B     —  Consent of Spouse
	 	 	 	 

i

 

VOTING AGREEMENT

     THIS VOTING AGREEMENT is made and entered into as of this 13th day of January, 2011, by and
among Myriant Technologies, Inc., a Delaware corporation (the “Company”), each holder of the
Company’s Class A Common Stock, US$0.0001 par value per share (“Class A Common Stock”), and Class B
Common Stock, US$0.0001 par value per share (“Class B Common Stock”), listed on Schedule A
(the “Investors”), and those certain stockholders of the Company listed on Schedule B (the
"Key Common Holders” and together collectively with the Investors, the “Stockholders”).

RECITALS

     A. Concurrently with the execution of this Agreement, the Company and the Investors that are
holders of the Class A Common Stock are entering into a Class A Common Stock Purchase Agreement
(the “Purchase Agreement”) providing for the issuance of shares of the Class A Common Stock.

     B. Concurrently with the execution of this Agreement, the Company and the Investors that are
holders of the Class B Common Stock are entering into a Debt Conversion Agreement (the “Conversion
Agreement”) providing for the issuance of shares of the Class B Common Stock.

     C. In connection with the entering into of the Purchase Agreement and the Conversion
Agreement, the parties desire to provide the Investors with the right, among other rights, to
designate the election of certain members of the Board of Directors of the Company (the “Board”) in
accordance with the terms of this Agreement.

     D. The Amended and Restated Certificate of Incorporation of the Company (the “Restated
Certificate”) provides that: (a) the holders of record of the shares of the Class A Common Stock,
exclusively and as a separate class, shall be entitled to elect three (3) directors of the Company
(the “Class A Common Directors”); (b) the holders of record of the shares of Class B Common Stock,
exclusively and as a separate class, shall be entitled to elect three (3) directors of the Company
(the “Class B Common Directors”); and (c) the holders of record of the shares of the Class A Common
Stock and the Class B Common Stock, voting together as a separate class, shall be entitled to elect
one (1) director of the Company (the “Independent Director”).

     E. The parties also desire to enter into this Agreement to set forth their agreements and
understandings with respect to how shares of the Company’s capital stock held by them will be voted
on or tendered in connection with (i) an acquisition of the Company and (ii) the authorization of
additional shares of Common Stock of the Company.

     NOW, THEREFORE, the parties agree as follows:

     1. Voting Provisions Regarding Board of Directors.

          1.1 Size of the Board. Each Stockholder agrees to vote, or cause to be voted, all
Shares (as defined below) owned by such Stockholder, or over which such Stockholder has voting
control, from time to time and at all times, in whatever manner as shall be necessary to ensure
that the size of the Board shall be set and remain at seven (7) directors and may be increased or
decreased only with the prior written consent of (a) PTT Chemical International Private Limited
(“PTTCH”) or (b) the approval of the Board, including the affirmative vote of at least one (1)
Class A Common Director designated by PTTCH. For purposes of this Agreement, the term “Shares”
shall mean and include any

1

 

securities of the Company the holders of which are entitled to vote for election of directors,
including without limitation, all shares of Common Stock, Class A Common Stock, and Class B Common
Stock, by whatever name called, now owned or subsequently acquired by a Stockholder, however
acquired, whether through stock splits, stock dividends, reclassifications, recapitalizations,
similar events or otherwise.

          1.2 Board Composition. Each Stockholder agrees to vote, or cause to be voted (to the
extent so entitled), all Shares owned by such Stockholder, or over which such Stockholder has
voting control, from time to time and at all times, in whatever manner as shall be necessary to
ensure that at each annual or special meeting of stockholders at which an election of directors is
held or pursuant to any written consent of the stockholders, the following persons shall be elected
to the Board:

               (a) Three (3) persons designated by PTTCH (the “PTTCH Designees”) as the Class A Common
Directors, for so long as such Stockholder and its Affiliates continue to own beneficially at least
ten percent (10%) of the number of shares of Class A Common Stock it acquires pursuant to the
Purchase Agreement (subject to appropriate adjustment in the event of any stock dividend, stock
split, combination or other similar recapitalization with respect to the Class A Common Stock),
which individuals will initially be Puntip Oungpasuk, Narongsak Jivakanun and Thitipong
Jurapornsiridee;

               (b) One (1) person designated by Norwood LDK, LLC (the “Norwood Designee”), for so long as
such Stockholder and its Affiliates continue to own beneficially at least ten percent (10%) of the
number of shares of Class B Common Stock it acquires pursuant to the Conversion Agreement (subject
to appropriate adjustment in the event of any stock dividend, stock split, combination or other
similar recapitalization with respect to the Class B Common Stock), which individual will initially
be Stephen J. Gatto;

               (c) One (1) person designated by Plainfield Direct LLC (the “Plainfield Designee”), for so
long as such Stockholder and its Affiliates continue to own beneficially at least ten percent (10%)
of the number of shares of Class B Common Stock it acquires pursuant to the Conversion Agreement
(subject to appropriate adjustment in the event of any stock dividend, stock split, combination or
other similar recapitalization with respect to the Class B Common Stock), which individual will
initially be Keith Carter;

               (d) One (1) person designated by Green Chem Second Edition, LLC (the “Green Chem Designee”),
for so long as such Stockholder and its Affiliates continue to own beneficially at least ten
percent (10%) of the number of shares of Class B Common Stock it acquires pursuant to the
Conversion Agreement (subject to appropriate adjustment in the event of any stock dividend, stock
split, combination or other similar recapitalization with respect to the Class B Common Stock),
which individual will initially be Steven M. Sisselman; and

               (e) One (1) person as the Independent Director who will be an individual not otherwise an
Affiliate of the Company who is mutually acceptable to and nominated by PTTCH, on the one hand, and
Norwood LDK, LLC, Plainfield Direct LLC and Green Chem Second Edition, LLC, on the other hand, and
who shall have the appropriate expertise and experience in the relevant industry that can enhance
the business of the Company.

     To the extent that any of clauses (a) through (e) above shall not be applicable, any member of
the Board who would otherwise have been designated in accordance with the terms thereof shall
instead be voted upon by all the stockholders of the Company entitled to vote thereon in accordance
with, and pursuant to, the Company’s Restated Certificate.

2

 

For purposes of this Agreement, an individual, firm, corporation, partnership, association, limited
liability company, trust or any other entity (collectively, a “Person”) shall be deemed an
"Affiliate” of another Person who, directly or indirectly, controls, is controlled by or is under
common control with such Person, including, without limitation, any general partner, managing
member, officer or director of such Person or any venture capital fund now or hereafter existing
that is controlled by one or more general partners or managing members of, or shares the same
management company with, such Person.

          1.3 Failure to Designate a Board Member. In the absence of any designation from the
Persons or groups with the right to designate a director as specified above, the director
previously designated by them and then serving shall be reelected if still eligible to serve as
provided herein.

          1.4 Removal of Board Members. Each Stockholder also agrees to vote, or cause to be
voted (to the extent so entitled), all Shares owned by such Stockholder, or over which such
Stockholder has voting control, from time to time and at all times, in whatever manner as shall be
necessary to ensure that:

               (a) no director elected pursuant to Subsections 1.2 or 1.3 of this Agreement
may be removed from office other than for cause unless (i) such removal is directed or approved by
the affirmative vote of the Person, or of the holders of at least a majority of the shares of
stock, entitled under Subsection 1.2 to designate that director or (ii) the Person(s)
originally entitled to designate or approve such director or occupy such Board seat pursuant to
Subsection 1.2 is no longer so entitled to designate or approve such director or occupy
such Board seat;

               (b) any vacancies created by the resignation, removal or death of a director elected pursuant
to Subsections 1.2 or 1.3 shall be filled pursuant to the provisions of this
Section 1;

               (c) upon the request of any party entitled to designate a director as provided in
Subsection 1.2(a) or 1.2(b) to remove such director, such director shall be
removed; and

               (d) All Stockholders agree to execute any written consents required to perform the obligations
of this Agreement, and the Company agrees at the request of any party entitled to designate
directors to call a special meeting of stockholders for the purpose of electing directors.

          1.5 No Liability for Election of Recommended Directors. No Stockholder, nor any
Affiliate of any Stockholder, shall have any liability as a result of designating a person for
election as a director for any act or omission by such designated person in his or her capacity as
a director of the Company, nor shall any Stockholder have any liability as a result of voting for
any such designee in accordance with the provisions of this Agreement.

     2. Vote to Increase Authorized Common Stock. Each Stockholder agrees to vote or cause
to be voted all Shares owned by such Stockholder, or over which such Stockholder has voting
control, from time to time and at all times, in whatever manner as shall be necessary to increase
the number of authorized shares of Common Stock from time to time to ensure that there will be
sufficient shares of Common Stock available for conversion of all of the shares of Class A Common
Stock and Class B Common Stock outstanding at any given time.

     3. Drag-Along Right.

          3.1 Definitions. A “Sale of the Company” shall mean a transaction that qualifies as a
“Deemed Liquidation Event” as defined in the Restated Certificate.

3

 

          3.2 Actions to be Taken. In the event that (i) at least a majority of the Board
(including at least two of the Class A Common Directors designated by PTTCH and at least two of the
Class B Common Directors) and (ii) the holders of at least a majority of the Class A Common Stock
and Class B Common Stock held by the Investors (including PTTCH) approve a Sale of the Company in
writing, specifying that this Section 3 shall apply to such transaction, then each
Stockholder hereby agrees:

          (a) if such transaction requires stockholder approval, with respect to all Shares that such
Stockholder owns or over which such Stockholder otherwise exercises voting power, to vote (in
person, by proxy or by action by written consent, as applicable) all Shares in favor of, and adopt,
such Sale of the Company (together with any related amendment to the Restated Certificate required
in order to implement such Sale of the Company) and to vote in opposition to any and all other
proposals that could reasonably be expected to delay or impair the ability of the Company to
consummate such Sale of the Company;

          (b) to execute and deliver all related documentation and take such other action in support of
the Sale of the Company as shall reasonably be requested by the Company or the selling Investors in
order to carry out the terms and provisions of this Section 3, including without limitation
executing and delivering instruments of conveyance and transfer, and any purchase agreement, merger
agreement, indemnity agreement, escrow agreement, consent, waiver, governmental filing, share
certificates duly endorsed for transfer (free and clear of impermissible liens, claims and
encumbrances) and any similar or related documents;

          (c) not to deposit, and to cause their Affiliates not to deposit, except as provided in this
Agreement, any Shares of the Company owned by such party or Affiliate in a voting trust or subject
any Shares to any arrangement or agreement with respect to the voting of such Shares, unless
specifically requested to do so by the acquiror in connection with the Sale of the Company;

          (d) to refrain from exercising any dissenters’ rights or rights of appraisal under applicable
law at any time with respect to such Sale of the Company; and

          (e) if the consideration to be paid in exchange for the Shares pursuant to this Section
3 includes any securities and due receipt thereof by any Stockholder would require under
applicable law (x) the registration or qualification of such securities or of any person as a
broker or dealer or agent with respect to such securities or (y) the provision to any Stockholder
of any information other than such information as a prudent issuer would generally furnish in an
offering made solely to “accredited investors” as defined in Regulation D promulgated under the
Securities Act of 1933, as amended, the Company may cause to be paid to any such Stockholder in
lieu thereof, against surrender of the Shares which would have otherwise been sold by such
Stockholder, an amount in cash equal to the fair value (as determined in good faith by the Company)
of the securities which such Stockholder would otherwise receive as of the date of the issuance of
such securities in exchange for the Shares.

          3.3 Exceptions. Notwithstanding the foregoing, a Stockholder will not be required to
comply with Subsection 3.2 above in connection with any proposed Sale of the Company (the
“Proposed Sale”) unless:

               (a) the liability for indemnification, if any, of such Stockholder in the Proposed Sale and
for the inaccuracy of any representations and warranties made by the Company or its Stockholders in
connection with such Proposed Sale, is several and not joint with any other Person (except to the
extent that funds may be paid out of an escrow established to cover breach of representations,
warranties and covenants of the Company as well as breach by any stockholder of any of

4

 

identical representations, warranties and covenants provided by all stockholders), and is pro
rata in proportion to, and does not exceed, the amount of consideration paid to such Stockholder in
connection with such Proposed Sale;

               (b) upon the consummation of the Proposed Sale, (A) each holder of each class or series of the
Company’s stock will receive the same form of consideration for their shares of such class or
series as is received by other holders in respect of their Shares of such same class or series of
stock and (B) each holder of a class of Common Stock will receive the same amount of consideration
per share of such class of Common Stock as is received by other holders in respect of their Shares
of such same class; provided, however, that, notwithstanding the foregoing, if the consideration to
be paid in exchange for the Shares pursuant to this Section 3 includes any securities and
due receipt thereof by any Stockholder would require under applicable law (x) the registration or
qualification of such securities or of any person as a broker or dealer or agent with respect to
such securities or (y) the provision to any Stockholder of any information other than such
information as a prudent issuer would generally furnish in an offering made solely to “accredited
investors” as defined in Regulation D promulgated under the Securities Act of 1933, as amended, the
Company may cause to be paid to any such Stockholder in lieu thereof, against surrender of the
Shares which would have otherwise been sold by such Stockholder, an amount in cash equal to the
fair value (as determined in good faith by the Company) of the securities which such Stockholder
would otherwise receive as of the date of the issuance of such securities in exchange for the
Shares; and

               (c) subject to clause (b) above, requiring the same form of consideration to be available to
the holders of any single class or series of capital stock, if any holders of any capital stock of
the Company are given an option as to the form and amount of consideration to be received as a
result of the Proposed Sale, all holders of such capital stock will be given the same option;
provided, however, that nothing in this Subsection 3.3(c) shall entitle any Stockholder to
receive any form of consideration that such Stockholder would be ineligible to receive as a result
of such Stockholder’s failure to satisfy any condition, requirement or limitation that is generally
applicable to the Company’s stockholders.

     4. Remedies.

          4.1 Covenants of the Company. The Company agrees to use its best efforts, within the
requirements of applicable law, to ensure that the rights granted under this Agreement are
effective and that the parties enjoy the benefits of this Agreement. Such actions include, without
limitation, the use of the Company’s best efforts to cause the nomination and election of the
directors as provided in this Agreement.

          4.2 Specific Enforcement. Each party acknowledges and agrees that each party hereto
will be irreparably damaged in the event any of the provisions of this Agreement are not performed
by the parties in accordance with their specific terms or are otherwise breached. Accordingly, it
is agreed that each of the Company and the Stockholders shall be entitled to seek an injunction to
prevent breaches of this Agreement, and to seek specific enforcement of this Agreement and its
terms and provisions in any action instituted in any court of the United States or any state having
subject matter jurisdiction.

          4.3 Remedies Cumulative. All remedies, either under this Agreement or by law or
otherwise afforded to any party, shall be cumulative and not alternative.

     5. Term. This Agreement shall be effective as of the date hereof and shall continue
in effect until and shall terminate upon the earliest to occur of: (a) the consummation of the
Company’s first underwritten public offering of its Common Stock (other than a registration
statement relating either to the sale of securities to employees of the Company pursuant to its
stock option, stock purchase or similar

5

 

plan or an SEC Rule 145 transaction); (b) the occurrence of a “Deemed Liquidation Event” as
defined in the Restated Certificate; and (c) termination of this Agreement in accordance with
Subsection 6.8 below.

     6. Miscellaneous.

          6.1 Additional Parties.

               (a) Notwithstanding anything to the contrary contained herein, if the Company issues
additional shares of the Company’s Class A Common Stock or Class B Common Stock after the date
hereof, any acquiror of such shares of Class A Common Stock or Class B Common Stock may become a
party to this Agreement by executing and delivering an additional counterpart signature page to
this Agreement and thereafter shall be deemed an “Investor” for all purposes hereunder. In such
case, Schedule A hereto may be amended by the Company to add such person without the
consent of the other parties hereto.

               (b) In the event that after the date of this Agreement, the Company enters into an agreement
with any Person to issue shares of capital stock to such Person (other than to a purchaser of Class
A Common Stock or Class B Common Stock described in Subsection 6.1(a) above), following
which such Person shall hold Shares constituting one percent (1%) or more of the Company’s then
outstanding capital stock (treating for this purpose all shares of Common Stock issuable upon
exercise of or conversion of outstanding options, warrants or convertible securities, as if
exercised and/or converted or exchanged), then the Company shall cause such Person, as a condition
precedent to entering into such agreement, to become a party to this Agreement by executing an
Adoption Agreement in the form attached hereto as Exhibit A, agreeing to be bound by and
subject to the terms of this Agreement as a Key Common Holder and thereafter such person shall be
deemed a Key Common Holder for all purposes under this Agreement. In such case, Schedule B
hereto may be amended by the Company to add such person without the consent of the other parties
hereto.

          6.2 Transfers. Each transferee or assignee of any Shares subject to this Agreement
shall continue to be subject to the terms hereof, and, as a condition precedent to the Company’s
recognizing such transfer, each transferee or assignee shall agree in writing to be subject to each
of the terms of this Agreement by executing and delivering an Adoption Agreement substantially in
the form attached hereto as Exhibit A. Upon the execution and delivery of an Adoption
Agreement by any transferee, such transferee shall be deemed to be a party hereto as if such
transferee were the transferor and such transferee’s signature appeared on the signature pages of
this Agreement and shall be deemed to be an Investor and Stockholder, or Key Common Holder and
Stockholder, as applicable. The Company shall not permit the transfer of the Shares subject to
this Agreement on its books or issue a new certificate representing any such Shares unless and
until such transferee shall have complied with the terms of this Subsection 6.2. Each
certificate representing the Shares subject to this Agreement if issued on or after the date of
this Agreement shall be endorsed by the Company with the legend set forth in Subsection
6.12.

          6.3 Successors and Assigns. The terms and conditions of this Agreement shall inure to
the benefit of and be binding upon the respective successors and assigns of the parties. Nothing
in this Agreement, express or implied, is intended to confer upon any party other than the parties
hereto or their respective successors and assigns any rights, remedies, obligations, or liabilities
under or by reason of this Agreement, except as expressly provided in this Agreement.

          6.4 Governing Law. This Agreement and any controversy arising out of or relating to
this Agreement shall be governed by and construed in accordance with the internal laws of the State
of New York, without regard to conflict of law principles that would result in the application of
any law other than the law of the State of New York.

6

 

          6.5 Counterparts. This Agreement may be executed in two or more counterparts, each of
which shall be deemed an original, but all of which together shall constitute one and the same
instrument. Counterparts may be delivered via facsimile, electronic mail (including pdf) or other
transmission method and any counterpart so delivered shall be deemed to have been duly and validly
delivered and be valid and effective for all purposes.

          6.6 Titles and Subtitles. The titles and subtitles used in this Agreement are used
for convenience only and are not to be considered in construing or interpreting this Agreement.

          6.7 Notices. All notices and other communications given or made pursuant to this
Agreement shall be in writing and shall be deemed effectively given upon the earlier of actual
receipt or: (a) personal delivery to the party to be notified, (b) when sent, if sent by
electronic mail or facsimile during normal business hours of the recipient, and if not sent during
normal business hours, then on the recipient’s next business day, provided, in either case, that
the facsimile transmission is promptly confirmed by telephone, (c) five (5) days after having been
sent by registered or certified mail, return receipt requested, postage prepaid, or (d) one (1)
business day after the business day of deposit with a nationally recognized overnight courier,
freight prepaid, specifying next business day delivery, with written verification of receipt. All
communications shall be sent to the respective parties at their address as set forth on
Schedule A or Schedule B hereto, or to such email address, facsimile number or
address as subsequently modified by written notice given in accordance with this Subsection
6.7. If notice is given to the Company, a copy shall also be sent to (a) DLA Piper LLP (US),
2000 University Avenue, East Palo Alto, California 94303-2215, USA, Attention: Curtis L. Mo,
facsimile: 650-687-1170, email: curtis.mo@dlapiper.com and (b) Byron S. Kalogerou, McDermott
Will & Emery, 28 State Street, 34th Floor, Boston, Massachusetts 02109-1775, USA, facsimile:
617-321-4605; email:bkalogerou@mwe.com. If notice is given to PTTCH, a copy shall also be given to
Allen & Overy (Thailand) Co., Ltd., 22nd Floor Sindhorn Building Tower III, 130-132 Wireless Road,
Lumpini Pathumwan, Bangkok 10330, Thailand, Attention: Arkrapol Pichedvanichok, facsimile: +66
(0)2 263 7699, email: arkrapol.pichedvanichok@allenovery.com.

          6.8 Consent Required to Amend, Terminate or Waive. This Agreement may be amended or
terminated and the observance of any term hereof may be waived (either generally or in a particular
instance and either retroactively or prospectively) only by a written instrument executed by: (a)
the Company; (b) the Key Common Holders holding a majority of the Shares then held collectively by
the Key Common Holders; and (c) the holders of at least a majority of the shares of Common Stock
issued or issuable upon conversion of the shares of Class A Common Stock and Class B Common Stock
held collectively by the Investors (voting as a single class and on an as-converted basis).
Notwithstanding the foregoing:

               (a) this Agreement may not be amended or terminated and the observance of any term of this
Agreement may not be waived with respect to any Key Common Holder without the written consent of
such Key Common Holder unless such amendment, termination or waiver applies to all Key Common
Holders in the same fashion;

               (b) the consent of the Key Common Holders shall not be required for any amendment or waiver if
such amendment or waiver either (A) is not directly applicable to the rights of the Key Common
Holders hereunder or (B) does not adversely affect the rights of the Key Common Holders in a manner
that is different than the effect on the rights of the other parties hereto;

               (c) Schedule A and Schedule B hereto may be amended by the Company from time
to time in accordance with Subsection 6.1 to add information regarding additional parties
without the consent of the other parties hereto;

7

 

               (d) any provision hereof may be waived by the waiving party on such party’s own behalf,
without the consent of any other party; and

               (e) Subsections 1.2(a) and 1.4 of this Agreement as it relates to the PTTCH
Designees shall not be amended or waived without the written consent of PTTCH; Subsections
1.2(b) and 1.4 of this Agreement as it relates to the Norwood Designee shall not be
amended or waived without the written consent of Norwood LDK, LLC; Subsections 1.2(c) and
1.4 of this Agreement as it relates to the Plainfield Designee shall not be amended or
waived without the written consent of Plainfield Direct LLC; and Subsections 1.2(d) and
1.4 of this Agreement as it relates to the Green Chem Designee shall not be amended or
waived without the written consent of Green Chem Second Edition, LLC.

The Company shall give prompt written notice of any amendment, termination or waiver hereunder to
any party that did not consent in writing thereto. Any amendment, termination or waiver effected
in accordance with this Subsection 6.8 shall be binding on each party and all of such
party’s successors and permitted assigns, whether or not any such party, successor or assignee
entered into or approved such amendment, termination or waiver. For purposes of this
Subsection 6.8, the requirement of a written instrument may be satisfied in the form of an
action by written consent of the Stockholders circulated by the Company and executed by the
Stockholder parties specified, whether or not such action by written consent makes explicit
reference to the terms of this Agreement.

          6.9 Delays or Omissions. No delay or omission to exercise any right, power or remedy
accruing to any party under this Agreement, upon any breach or default of any other party under
this Agreement, shall impair any such right, power or remedy of such non-breaching or
non-defaulting party nor shall it be construed to be a waiver of any such breach or default, or an
acquiescence therein, or of or in any similar breach or default thereafter occurring; nor shall any
waiver of any single breach or default be deemed a waiver of any other breach or default previously
or thereafter occurring. Any waiver, permit, consent or approval of any kind or character on the
part of any party of any breach or default under this Agreement, or any waiver on the part of any
party of any provisions or conditions of this Agreement, must be in writing and shall be effective
only to the extent specifically set forth in such writing.

          6.10 Severability. The invalidity or unenforceability of any provision hereof shall
in no way affect the validity or enforceability of any other provision.

          6.11 Entire Agreement. This Agreement (including the Exhibits and Schedules hereto),
the Restated Certificate and the other Transaction Agreements (as defined in the Purchase
Agreement) constitute the full and entire understanding and agreement between the parties with
respect to the subject matter hereof, and any other written or oral agreement relating to the
subject matter hereof existing between the parties is expressly canceled.

          6.12 Legend on Share Certificates. Each certificate representing any Shares issued
after the date hereof shall be endorsed by the Company with a legend reading substantially as
follows:

“THE SHARES EVIDENCED HEREBY ARE SUBJECT TO A VOTING AGREEMENT, AS MAY BE AMENDED
FROM TIME TO TIME, (A COPY OF WHICH MAY BE OBTAINED UPON WRITTEN REQUEST FROM THE
COMPANY), AND BY ACCEPTING ANY INTEREST IN SUCH SHARES THE PERSON ACCEPTING SUCH
INTEREST SHALL BE DEEMED TO AGREE TO AND SHALL BECOME BOUND BY ALL THE PROVISIONS OF
THAT VOTING AGREEMENT, INCLUDING CERTAIN RESTRICTIONS ON TRANSFER AND OWNERSHIP SET
FORTH THEREIN.”

8

 

The Company, by its execution of this Agreement, agrees that it will cause the certificates
evidencing the Shares issued after the date hereof to bear the legend required by this
Subsection 6.12, and it shall supply, free of charge, a copy of this Agreement to any
holder of a certificate evidencing Shares upon written request from such holder to the Company at
its principal office. The parties to this Agreement do hereby agree that the failure to cause the
certificates evidencing the Shares to bear the legend required by this Subsection 6.12
herein and/or the failure of the Company to supply, free of charge, a copy of this Agreement as
provided hereunder shall not affect the validity or enforcement of this Agreement.

          6.13 Stock Splits, Stock Dividends, etc. In the event of any issuance of Shares of
the Company’s voting securities hereafter to any of the Stockholders (including, without
limitation, in connection with any stock split, stock dividend, recapitalization, reorganization,
or the like), such Shares shall become subject to this Agreement and shall be endorsed with the
legend set forth in Subsection 6.12.

          6.14 Manner of Voting. The voting of Shares pursuant to this Agreement may be
effected in person, by proxy, by written consent or in any other manner permitted by applicable
law. For the avoidance of doubt, voting of the Shares pursuant to this Agreement need not make
explicit reference to the terms of this Agreement.

          6.15 Further Assurances. At any time or from time to time after the date hereof, the
parties agree to cooperate with each other, and at the request of any other party, to execute and
deliver any further instruments or documents and to take all such further action as the other party
may reasonably request in order to evidence or effectuate the consummation of the transactions
contemplated hereby and to otherwise carry out the intent of the parties hereunder.

          6.16 Dispute Resolution. Any unresolved controversy or claim arising out of or
relating to this Agreement, except (i) as otherwise provided in this Agreement or (ii) any such
controversies or claims arising out of either party’s intellectual property rights for which a
provisional remedy or equitable relief is sought, shall be submitted to arbitration administered by
the American Arbitration Association (the “AAA”) in accordance with the International Commercial
Arbitration Rules then in effect. There shall be one (1) arbitrator mutually agreed upon by the
parties from the names of potential arbitrators proposed by the AAA. If no agreement on the sole
arbitrator can be reached within thirty (30) days after names of potential arbitrators have been
proposed by the AAA, then the AAA shall select the sole arbitrator, who shall have at least ten
(10) years experience in corporate finance transactions of the type provided for in this Agreement.
The arbitration shall take place in New York, New York, and any award shall be final and binding
and judgment thereon may be entered in any court having jurisdiction thereof. Each party will bear
its own costs in respect of any disputes arising under this Agreement. Each of the parties to this
Agreement consents to personal jurisdiction for any equitable action sought in the U.S. District
Court for the Southern District of New York or any court of the State of New York having subject
matter jurisdiction.

          6.17 Costs of Enforcement. If any party to this Agreement seeks to enforce its rights
under this Agreement by legal proceedings, the non-prevailing party shall pay all costs and
expenses incurred by the prevailing party, including, without limitation, all reasonable attorneys’
fees.

          6.18 Aggregation of Stock. All Shares held or acquired by a Stockholder and/or its
Affiliates shall be aggregated together for the purpose of determining the availability of any
rights under this Agreement, and such Affiliated persons may apportion such rights as among
themselves in any manner they deem appropriate.

          6.19 Spousal Consent. If any individual Stockholder is married on the date of this
Agreement, such Stockholder’s spouse shall execute and deliver to the Company a consent of spouse
in

9

 

the form of Exhibit B hereto (“Consent of Spouse”), effective on the date hereof.
Notwithstanding the execution and delivery thereof, such consent shall not be deemed to confer or
convey to the spouse any rights in such Stockholder’s Shares that do not otherwise exist by
operation of law or the agreement of the parties. If any individual Stockholder should marry or
remarry subsequent to the date of this Agreement, such Stockholder shall within thirty (30) days
thereafter obtain his/her new spouse’s acknowledgement of and consent to the existence and binding
effect of all restrictions contained in this Agreement by causing such spouse to execute and
deliver a Consent of Spouse acknowledging the restrictions and obligations contained in this
Agreement and agreeing and consenting to the same.

[Signature Page Follows]

10

 

     IN WITNESS WHEREOF, the parties have executed this Voting Agreement as of the date first
written above.

	 	 	 	 	 
	 	COMPANY:

MYRIANT TECHNOLOGIES, INC.

 	 
	 	By:  	/s/ Stephen J. Gatto
 	 
	 	 	Stephen J.  Gatto 	 
	 	 	Chairman and CEO

Address:

1 Pinehill Drive

Batterymarch Park II, Suite 301

Quincy, MA 02169-4801

Facsimile:  (617) 657-5210

Email:  sgatto@myriant.com 	 
	 
	 	KEY COMMON HOLDERS:

NORWOOD LDK, LLC

 	 
	 	By:  	/s/ Stephen J. Gatto
 	 
	 	 	Name:  	Stephen J. Gatto 	 
	 	 	Title:  	President 	 
	 
	 	ITERA ETHANOL, LLC

 	 
	 	By:  	/s/ Steven M. Sisselman
 	 
	 	 	Name:  	Steven M. Sisselman 	 
	 	 	Title:  	President 	 
	 
	 	CAMULOS BIOENERGY PARTNERS LLC

 	 
	 	By:  	/s/ Michael Iuliano
 	 
	 	 	Name:  	Michael Iuliano 	 
	 	 	Title:  	Authorized Signatory 	 
	 

SIGNATURE PAGE TO MYRIANT TECHNOLOGIES, INC. VOTING AGREEMENT

 

 

	 	 	 	 	 
	 	INVESTORS:

PTT CHEMICAL INTERNATIONAL PRIVATE LIMITED

 	 
	 	By:  	/s/ Narongsak Jivakanun
 	 
	 	 	Name:  	Narongsak Jivakanun 	 
	 	 	Title:  	Chief Executive Officer 	 
	 
	 	GREEN CHEM HOLDINGS, LLC

 	 
	 	By:  	/s/ Steven M. Sisselman
 	 
	 	 	Name:  	Steven M. Sisselman 	 
	 	 	Title:  	President 	 
	 
	 	GREEN CHEM SECOND EDITION, LLC

 	 
	 	By:  	/s/ Steven M. Sisselman
 	 
	 	 	Name:  	Steven M. Sisselman 	 
	 	 	Title:  	President 	 
	 
	 	PLAINFIELD FINANCE II LLC

 	 
	 	By:  	/s/ Thomas X. Fritsch
 	 
	 	 	Name:  	Thomas X. Fritsch 	 
	 	 	Title:  	Co-General Counsel 	 
	 

	 	 	 	 	 
	 	PLAINFIELD DIRECT LLC

 	 
	 	By:  	/s/ Thomas X. Fritsch
 	 
	 	 	Name:  	Thomas X. Fritsch 	 
	 	 	Title:  	Co-General Counsel 	 
	 
	 	STEPHEN J. GATTO

 	 
	 	/s/ Stephen J. Gatto
 	 

SIGNATURE PAGE TO MYRIANT TECHNOLOGIES, INC. VOTING AGREEMENT

 

 

SCHEDULE A

INVESTORS

	 	 	 
	Name and Address	 	Number and Class of Shares Held
	PTT Chemical International Private Limited

391B Orchard Road, #15-05/08

Ngee Ann City Tower B

Singapore 238874

Attn: Mr. Narongsak Jivakanun

Fax: +65.6.734.3397

	 	11,214,953 Class A Common
	 
	 	 
	 
	 	 
	Plainfield Direct LLC and 

Plainfield Finance II LLC 

c/o Plainfield Asset Management, LLC

333 Ludlow Street

Stamford, CT 06902

Attn: James Healy

Jim.healy@pfam.com

Fax: 203.302.1779

	 	2,846,870 Class B Common

3,504,370 Common (including
warrants exercisable for Common
Stock)
	 
	 	 
	Green Chem Holdings, LLC

9995 Gate Parkway N., Suite 400

Jacksonville, FL 32246

	 	82,942 Class B Common

147,820 Common
	 
	 	 
	Green Chem Second Edition, LLC

9995 Gate Parkway N., Suite 400

Jacksonville, FL 32246

	 	64,617 Class B Common

182,621 warrants exercisable
for Common Stock
	 
	 	 
	Stephen J. Gatto 

1 Pinehill Drive

Batterymark Park II, Suite 301 

Quincy, MA 02169-5210 

sgatto@myriant.com

Fax: 617.657.5210

	 	50,476 Class B Common

134,089 Common (including
warrants exercisable for Common
Stock)

Schedule A-1

 

 

SCHEDULE B

KEY COMMON HOLDERS

	 	 	 
	Name and Address	 	Number of Shares Held
	Norwood LDK, LLC 

c/o Stephen Gatto 

29 Royal Court 

Norwood, MA 02062

	 	3,057,004 Common
	 
	 	 
	Itera Ethanol, LLC

9995 Gate Parkway, Suite 400

Jacksonville, FL 32246

	 	373,784 Common (including warrants

exercisable for Common Stock)
	 
	 	 
	Camulos BioEnergy Partners LLC 

Three Landmark Square, 4th Floor

Stamford, CT 06901

	 	251,043 Common (including warrants

exercisable for Common Stock)

Schedule B-1

 

 

EXHIBIT A

ADOPTION AGREEMENT

     This Adoption Agreement (“Adoption Agreement”) is executed on ___________________, 20__, by
the undersigned (the “Holder”) pursuant to the terms of that certain Voting Agreement dated as of
January __, 2011 (the “Agreement”), by and among the Company and certain of its Stockholders, as
such Agreement may be amended or amended and restated hereafter. Capitalized terms used but not
defined in this Adoption Agreement shall have the respective meanings ascribed to such terms in the
Agreement. By the execution of this Adoption Agreement, the Holder agrees as follows.

     1.1 Acknowledgement. Holder acknowledges that Holder is acquiring certain shares of
the capital stock of the Company (the “Stock”)[ or options, warrants or other rights to purchase
such Stock (the “Options”)], for one of the following reasons (Check the correct box):

	 	o	 	as a transferee of Shares from a party in such party’s capacity as an “Investor”
bound by the Agreement, and after such transfer, Holder shall be considered an
“Investor” and a “Stockholder” for all purposes of the Agreement.
	 
	 	o	 	as a transferee of Shares from a party in such party’s capacity as a “Key Common
Holder” bound by the Agreement, and after such transfer, Holder shall be considered a
“Key Common Holder” and a “Stockholder” for all purposes of the Agreement.
	 
	 	o	 	as a new Investor in accordance with Subsection 6.1(a) of the Agreement, in
which case Holder will be an “Investor” and a “Stockholder” for all purposes of the
Agreement.
	 
	 	o	 	in accordance with Subsection 6.1(b) of the Agreement, as a new party who is
not a new Investor, in which case Holder will be a “Stockholder” for all purposes of
the Agreement.

     1.2 Agreement. Holder hereby (a) agrees that the Stock [Options], and any other
shares of capital stock or securities required by the Agreement to be bound thereby, shall be bound
by and subject to the terms of the Agreement and (b) adopts the Agreement with the same force and
effect as if Holder were originally a party thereto.

     1.3 Notice. Any notice required or permitted by the Agreement shall be given to
Holder at the address or facsimile number listed below Holder’s signature hereto.

	 	 	 	 

	HOLDER:

	 	 	ACCEPTED AND AGREED:
	 

	 	 	 
	By:

	 	MYRIANT TECHNOLOGIES, INC.
	Name and Title of Signatory

	 	
	 

	 	 	 
	 

	 	 	 
	Address:

	 	By:

	 

	 	 	 
	 	 	Title:

	 

	 	 	 
	Facsimile Number: 
	 	 	 

A-1

 

EXHIBIT B

CONSENT OF SPOUSE

          I, [____________________], spouse of [______________], acknowledge that I have read the Voting
Agreement, dated as of January __, 2011, to which this Consent is attached as Exhibit B
(the “Agreement”), and that I know the contents of the Agreement. I am aware that the Agreement
contains provisions regarding the voting and transfer of shares of capital stock of the Company
that my spouse may own, including any interest I might have therein.

          I hereby agree that my interest, if any, in any shares of capital stock of the Company subject
to the Agreement shall be irrevocably bound by the Agreement and further understand and agree that
any community property interest I may have in such shares of capital stock of the Company shall be
similarly bound by the Agreement.

          I am aware that the legal, financial and related matters contained in the Agreement are
complex and that I am free to seek independent professional guidance or counsel with respect to
this Consent. I have either sought such guidance or counsel or determined after reviewing the
Agreement carefully that I will waive such right.

	 	 	 	 	 
	Dated:
	 	 
	 	 	[Name of Key Common Holder’s Spouse, if any]	 
	 	 	 
	 	 	 
	 

B-1exv4w4

Exhibit 4.4

Execution Version

RIGHT OF FIRST REFUSAL AND CO-SALE AGREEMENT

 

 

TABLE OF CONTENTS

	 	 	 	 	 
	 	 	Page	 
	1. Definitions
	 	 	1	 
	 
	 	 	 	 
	1.1. “Affiliate”
	 	 	1	 
	1.2. “Capital Stock”
	 	 	1	 
	1.3. “Class A Common Holders”
	 	 	2	 
	1.4. “Class A Common Majority Holder Notice”
	 	 	2	 
	1.5. “Class B Common Holders”
	 	 	2	 
	1.6. “Class B Common Holder Notice”
	 	 	2	 
	1.7. “Common Stock”
	 	 	2	 
	1.8. “Company Notice”
	 	 	2	 
	1.9. “Entity Key Holder”
	 	 	2	 
	1.10. “Investors”
	 	 	2	 
	1.11. “Key Holders”
	 	 	2	 
	1.12. “Proposed Key Holder Transfer”
	 	 	2	 
	1.13. “Proposed Transfer Notice”
	 	 	2	 
	1.14. “Prospective Transferee”
	 	 	2	 
	1.15. “Right of Co-Sale”
	 	 	2	 
	1.16. “Right of First Refusal”
	 	 	3	 
	1.17. “Secondary Notice”
	 	 	3	 
	1.18. “Secondary Refusal Right”
	 	 	3	 
	1.19. “Tertiary Notice”
	 	 	3	 
	1.20. “Tertiary Refusal Right”
	 	 	3	 
	1.21. “Transfer Stock”
	 	 	3	 
	1.22. “Undersubscription Notice”
	 	 	3	 
	 
	 	 	 	 
	2. Agreement Among the Company, the Investors and the Key Holders
	 	 	3	 
	 
	 	 	 	 
	2.1. Right of First Refusal
	 	 	3	 
	2.2. Right of Co-Sale
	 	 	5	 
	2.3. Effect of Failure to Comply
	 	 	7	 
	 
	 	 	 	 
	3. Exempt Transfers
	 	 	7	 
	 
	 	 	 	 
	3.1. Exempted Transfers
	 	 	7	 
	3.2. Exempted Offerings
	 	 	8	 
	3.3. Prohibited Transferees
	 	 	8	 
	 
	 	 	 	 
	4. Legend 
	 	 	8	 
	 
	 	 	 	 
	5. Lock-Up
	 	 	8	 
	 
	 	 	 	 
	5.1. Agreement to Lock-Up
	 	 	8	 
	5.2. Stop Transfer Instructions
	 	 	9	 
	 
	 	 	 	 
	6. Miscellaneous
	 	 	9	 
	 
	 	 	 	 
	6.1. Term
	 	 	9	 
	6.2. Stock Split
	 	 	9	 
	6.3. Ownership
	 	 	9	 

i

 

	 	 	 	 	 
	 	 	Page	 
	6.4. Dispute Resolution
	 	 	9	 
	6.5. Notices
	 	 	10	 
	6.6. Entire Agreement
	 	 	10	 
	6.7. Delays or Omissions
	 	 	10	 
	6.8. Amendment; Waiver and Termination
	 	 	10	 
	6.9. Assignment of Rights
	 	 	11	 
	6.10. Severability
	 	 	11	 
	6.11. Additional Investors
	 	 	11	 
	6.12. Governing Law
	 	 	11	 
	6.13. Titles and Subtitles
	 	 	12	 
	6.14. Counterparts
	 	 	12	 
	6.15. Aggregation of Stock
	 	 	12	 
	6.16. Specific Performance
	 	 	12	 
	6.17. Additional Key Holders
	 	 	12	 
	6.18. Consent of Spouse
	 	 	12	 
	Schedule A  —  Investors
	 	 	 	 
	Schedule B  —  Key Holders
	 	 	 	 
	Exhibit A   —   Consent of Spouse
	 	 	 	 

ii

 

RIGHT OF FIRST REFUSAL

AND CO-SALE AGREEMENT

     THIS RIGHT OF FIRST REFUSAL AND CO-SALE AGREEMENT is made and entered into as of this 13th day
of January, 2011, by and among Myriant Technologies, Inc., a Delaware corporation (the “Company”),
each holder of the Company’s Class A Common Stock, US$0.0001 par value per share (“Class A Common
Stock”), and Class B Common Stock, US$0.0001 par value per share (“Class B Common Stock”), listed
on Schedule A (the “Investors”), and certain holders of the Common Stock of the Company,
US$0.0001 par value per share, listed on Schedule B (such holders together with the
Investors and the other persons referred to in Section 1.11, collectively, the “Key Holders”).

RECITALS

     A. Each current Key Holder is the beneficial owner of the number of shares of Capital Stock,
or of options to purchase Capital Stock, set forth opposite the name of such Key Holder on
Schedule A or Schedule B.

     B. Concurrently with the execution of this Agreement, the Company and the Investor that is the
holder of the Class A Common Stock are entering into a Class A Common Stock Purchase Agreement (the
“Purchase Agreement”) providing for the issuance of shares of the Class A Common Stock.

     C. Concurrently with the execution of this Agreement, the Company and the Investors that are
holders of the Class B Common Stock are entering into a Debt Conversion Agreement (the “Conversion
Agreement”) providing for the issuance of shares of the Class B Common Stock.

     D. In order to induce the Investors to enter into the Purchase Agreement and the Conversion
Agreement, the Company and the Key Holders desire to enter into this Agreement with the Investors.

     NOW, THEREFORE, the Company, the Key Holders and the Investors agree as follows:

     1. Definitions.

          1.1. “Affiliate” means, with respect to any specified Investor, any other Person who directly
or indirectly, controls, is controlled by or is under common control with such Investor, including
without limitation any general partner, managing member, officer or director of such Investor, or
any venture capital fund now or hereafter existing which is controlled by one or more general
partners or managing members of, or shares the same management company with, such Investor.

          1.2. “Capital Stock” means (a) shares of Common Stock, Class A Common Stock and Class B Common
Stock (whether now outstanding or hereafter issued in any context), (b) shares of Common Stock
issued or issuable upon conversion of Class A Common Stock and Class B Common Stock and (c) shares
of Common Stock issued or issuable upon exercise or conversion, as applicable, of stock options,
warrants or other convertible securities of the Company, in each case now owned or subsequently
acquired by any Key Holder, any Investor, or their respective successors or permitted transferees
or assigns. For purposes of the number of shares of Capital Stock held by an Investor or Key Holder
(or any other calculation based thereon), all shares of Class A Common Stock and Class B Common
Stock shall be deemed to have been converted into Common Stock at the then-applicable conversion
ratio.

          1.3. “Class A Common Holders” means Investors that hold the Class A Common Stock.

1

 

          1.4. “Class A Common Majority Holder Notice” means written notice from the holder of a
majority of Class A Common Stock notifying the Company and the selling Key Holder that such holder
intends to exercise its Secondary Refusal Right as to a portion of the Transfer Stock with respect
to any Proposed Key Holder Transfer.

          1.5. “Class B Common Holders” means Investors that hold the Class B Common Stock.

          1.6. “Class B Common Holder Notice” means written notice from a Class B Common Holder
notifying the Company and the selling Key Holder that such Class B Common Holder intends to
exercise its Tertiary Refusal Right as to a portion of the Transfer Stock with respect to any
Proposed Key Holder Transfer.

          1.7. “Common Stock” means shares of Common Stock of the Company, US$0.0001 par value per
share.

          1.8. “Company Notice” means written notice from the Company notifying the selling Key Holders
that the Company intends to exercise its Right of First Refusal as to some or all of the Transfer
Stock with respect to any Proposed Key Holder Transfer.

          1.9. “Entity Key Holder” means a Key Holder that is a corporation, partnership, trust, joint
venture, limited liability company, association, organization or other entity.

          1.10. “Investors” means the persons named on Schedule A hereto, each person to whom
the rights of an Investor are assigned pursuant to Subsection 6.9, each person who
hereafter becomes a signatory to this Agreement pursuant to Subsection 6.11 and any one of
them, as the context may require.

          1.11. “Key Holders” means any Holder of greater than one percent (1%) of the Capital Stock of
the Company (treating for this purpose all shares of Common Stock issuable upon exercise of or
conversion of outstanding options, warrants or convertible securities, as if exercised and/or
converted or exchanged), each person to whom the rights of a Key Holder are assigned pursuant to
Subsection 3.1, each person who hereafter becomes a signatory to this Agreement pursuant to
Subsection 6.9 or 6.17 and any one of them, as the context may require.

          1.12. “Proposed Key Holder Transfer” means any assignment, sale, offer to sell, pledge,
mortgage, hypothecation, encumbrance, disposition of or any other like transfer or encumbering of
any Transfer Stock (or any interest therein) proposed by any of the Key Holders.

          1.13. “Proposed Transfer Notice” means written notice from a Key Holder setting forth the
terms and conditions of a Proposed Key Holder Transfer.

          1.14. “Prospective Transferee” means any person to whom a Key Holder proposes to make a
Proposed Key Holder Transfer.

          1.15. “Right of Co-Sale” means the right, but not an obligation, of an Investor to participate
in a Proposed Key Holder Transfer on the terms and conditions specified in the Proposed Transfer
Notice.

2

 

          1.16. “Right of First Refusal” means the right, but not an obligation, of the Company, or its
permitted transferees or assigns, to purchase some or all of the Transfer Stock with
respect to a Proposed Key Holder Transfer, on the terms and conditions specified in the
Proposed Transfer Notice.

          1.17. “Secondary Notice” means written notice from the Company notifying the holder of a
majority of the Class A Common and the selling Key Holder that the Company does not intend to
exercise its Right of First Refusal as to all shares of Transfer Stock with respect to any Proposed
Key Holder Transfer.

          1.18. “Secondary Refusal Right” means the right, but not an obligation, of the holder of a
majority of Class A Common Stock to purchase any Transfer Stock not purchased pursuant to the
Right of First Refusal, on the terms and conditions specified in the Proposed Transfer Notice.

          1.19. “Tertiary Notice” means written notice from the Company notifying the Class B Common
Holders and the selling Key Holder that the Company and the Class A Common Holders do not intend to
exercise their Right of First Refusal and Secondary Refusal Right as to all shares of Transfer
Stock with respect to any Proposed Key Holder Transfer.

          1.20. “Tertiary Refusal Right” means the right, but not an obligation, of each Class B Common
Holder to purchase up to its pro rata portion (based upon the total number of shares of Capital
Stock then held by all Investors) of any Transfer Stock not purchased pursuant to the Right of
First Refusal and the Secondary Refusal Right, on the terms and conditions specified in the
Proposed Transfer Notice.

          1.21. “Transfer Stock” means shares of Capital Stock owned by a Key Holder, or issued to a Key
Holder after the date hereof (including, without limitation, in connection with any stock split,
stock dividend, recapitalization, reorganization, or the like).

          1.22. “Undersubscription Notice” means written notice from an Investor notifying the Company
and the selling Key Holder that such Investor intends to exercise its option to purchase all or any
portion of the Transfer Stock not purchased pursuant to the Right of First Refusal, the Secondary
Refusal Right or the Tertiary Refusal Right.

     2. Agreement Among the Company, the Investors and the Key Holders.

          2.1. Right of First Refusal.

               (a) Grant. Subject to the terms of Section 3 below, each Key Holder hereby
unconditionally and irrevocably grants to the Company a Right of First Refusal to purchase all or
any portion of Transfer Stock that such Key Holder may propose to transfer in a Proposed Key Holder
Transfer, at the same price and on the same terms and conditions as those offered to the
Prospective Transferee.

               (b) Notice. Each Key Holder proposing to make a Proposed Key Holder Transfer must
deliver a Proposed Transfer Notice to the Company and each Investor not later than seventy-five
(75) days prior to the consummation of such Proposed Key Holder Transfer. Such Proposed
Transfer Notice shall contain the material terms and conditions (including price and form of
consideration) of the Proposed Key Holder Transfer and the identity of the Prospective Transferee.
To exercise its Right of First Refusal under this Subsection 2.1(b), the Company must
deliver a Company Notice to the selling Key Holder within fifteen (15) days after delivery of the
Proposed Transfer Notice. In the event of a conflict between this Agreement and any other
agreement that may have been entered

3

 

into by a Key Holder with the Company that contains a
pre-existing right of first refusal, the Company
and the Key Holder acknowledge and agree that the terms of this Agreement shall control and
the pre-existing right of first refusal shall be deemed satisfied by compliance with Subsection
2.1(a) and this Subsection 2.1(b).

               (c) Grant of Secondary Refusal Right to Class A Common Holders. Subject to the terms
of Section 3 below, each Key Holder hereby unconditionally and irrevocably grants to the
holder of a majority of Class A Common Stock a Secondary Refusal Right to purchase all or any
portion of the Transfer Stock not purchased by the Company pursuant to the Right of First Refusal.
If the Company does not intend to exercise its Right of First Refusal with respect to all Transfer
Stock subject to a Proposed Key Holder Transfer, the Company must deliver a Secondary Notice to the
selling Key Holder and to the holder of a majority of Class A Common Stock to that effect no later
than fifteen (15) days after the selling Key Holder delivers the Proposed Transfer Notice to the
Company. To exercise its Secondary Refusal Right, the holder of a majority of Class A Common Stock
must deliver a Class A Common Majority Holder Notice to the selling Key Holder and the Company
within fifteen (15) days after the Company’s deadline for its delivery of the Secondary Notice as
provided in the preceding sentence (the “Secondary Notice Period”).

               (d) Grant of Tertiary Refusal Right to Investors. Subject to the terms of Section
3 below, each Key Holder hereby unconditionally and irrevocably grants to the Class B Common
Holders a Tertiary Refusal Right to purchase all or any portion of the Transfer Stock not purchased
by the Company and the holder of a majority of Class A Common pursuant to the Right of First
Refusal and the Secondary Refusal Right. If the Company does not intend to exercise its Right of
First Refusal, and the Company and the selling Key Holder do not receive the Class A Common
Majority Holder Notice with respect to all Transfer Stock subject to a Proposed Key Holder
Transfer, the Company must deliver a Tertiary Notice to the selling Key Holder and to the Class B
Common Holders to that effect immediately after the expiration of the Secondary Notice Period. To
exercise its Tertiary Refusal Right, a Class B Common Holder must deliver a Class B Common Holder
Notice to the selling Key Holder and the Company within fifteen (15) days after the Company’s
deadline for its delivery of the Tertiary Notice as provided in the preceding sentence (the
“Tertiary Notice Period”).

               (e) Undersubscription of Transfer Stock. If options to purchase have been exercised
by the Company, the holder of a majority of Class A Common Stock and the Class B Common Holders
with respect to some but not all of the Transfer Stock subject to a Proposed Key Holder Transfer by
the end of the Tertiary Notice Period, then the Company shall, immediately after the expiration of
the Tertiary Notice Period, send written notice (the “Company Undersubscription Notice”) to the
holder of a majority of Class A Common Stock who partially exercised its Secondary Refusal Right
within the Secondary Notice Period (the “Exercising Common A Holder”). The Exercising Common A
Holder shall, subject to the provisions of this Subsection 2.1(e), have an additional
option to purchase all or any part of the balance of any such remaining unsubscribed shares of
Transfer Stock on the terms and conditions set forth in the Proposed Transfer Notice. To exercise
such option, the Exercising Common A Holder must deliver an Undersubscription Notice to the selling
Key Holder and the Company within ten (10) days after the expiration of the Tertiary Notice Period
(the “Exercising Common A Holder Notice Period”). If the options to purchase the remaining shares
are exercised in full by the Exercising Common A Holder, the Company shall immediately notify the
Exercising Common A Holder, all of the Class B Common Holders and the selling Key Holder of that
fact.

               (f) If options to purchase have been exercised by the Company, the holder of a majority of
Class A Common, the Class B Common Holders and the Exercising Common A Holder with respect to some
but not all of the Transfer Stock subject to a Proposed Key Holder Transfer by the end of the
Exercising Common A Holder Notice Period, then the Company shall, immediately after the

4

 

expiration
of the Exercising Common A Holder Notice Period, send written notice to those Class B
Common Holders who fully exercised their options within the Tertiary Notice Period (the
"Exercising Common B Holders”). Each Exercising Common B Holder shall have an additional option to
purchase all or any part of the balance of any such remaining unsubscribed shares of Transfer Stock
on the terms and conditions set forth in the Proposed Transfer Notice. To exercise such option,
such Exercising Common B Holder must deliver an Undersubscription Notice to the selling Key Holder
and the Company within ten (10) days after the expiration of the Exercising Common A Holder Notice
Period (the “Exercising Common B Holder Notice Period”). In the event there are two or more such
Exercising Common B Holders that choose to exercise the last-mentioned option for a total number of
remaining shares in excess of the number available, the remaining shares available for purchase
under this Section 2.1(f) shall be allocated to such Exercising Common B Holders pro rata
based on the number of shares of Capital Stock such Exercising Common B Holders have elected to
purchase. If the options to purchase the remaining shares are exercised in full by the Exercising
Common B Holders by the end of the Exercising Common B Holder Notice Period, the Company shall
immediately notify all of the Exercising Common B Holders and the selling Key Holder of that fact.

               (g) Consideration; Closing. If the consideration proposed to be paid for the Transfer
Stock is in property, services or other non-cash consideration, the fair market value of the
consideration shall be as determined in good faith by the Company’s Board of Directors and as set
forth in the Company Notice. If the Company or any Investor cannot for any reason pay for the
Transfer Stock in the same form of non-cash consideration, the Company or such Investor may pay the
cash value equivalent thereof, as determined in good faith by the Board of Directors and as set
forth in the Company Notice. The closing of the purchase of Transfer Stock by the Company and the
Investors shall take place, and all payments from the Company and the Investors shall have been
delivered to the selling Key Holder, by the later of (i) the date specified in the Proposed
Transfer Notice as the intended date of the Proposed Key Holder Transfer and (ii) ninety (90) days
after delivery of the Proposed Transfer Notice.

          2.2. Right of Co-Sale.

               (a) Exercise of Right. If any Transfer Stock subject to a Proposed Key Holder
Transfer is not purchased pursuant to Subsection 2.1 above and thereafter is to be sold to
a Prospective Transferee, each respective Investor may elect to exercise its Right of Co-Sale and
participate on a pro rata basis in the Proposed Key Holder Transfer as set forth in Subsection
2.2(b) below and otherwise on the same terms and conditions specified in the Proposed Transfer
Notice (provided that if an Investor wishes to sell Class A Common Stock or Class B Common Stock,
the price set forth in the Proposed Transfer Notice shall be appropriately adjusted based on the
conversion ratio of the Class A Common Stock or Class B Common Stock into Common Stock). Each
Investor who desires to exercise its Right of Co-Sale must give the selling Key Holder written
notice to that effect within ten (10) days after the expiration of the Exercising Common B Holder
Notice Period described above, and upon giving such notice such Investor shall be deemed to have
effectively exercised the Right of Co-Sale.

               (b) Shares Includable. Each Investor who timely exercises such Investor’s Right of
Co-Sale by delivering the written notice provided for above in Subsection 2.2(a) may
include in the Proposed Key Holder Transfer such number of shares of such Investor’s Capital Stock
(which number may represent some or all of such Investor’s Capital Stock) equal to the product
obtained by multiplying (i) the aggregate number of shares of Transfer Stock subject to the
Proposed Key Holder Transfer (excluding shares purchased by the Company or the Investors pursuant
to the Right of First Refusal, the Secondary Refusal Right, the Tertiary Refusal Right or any
Undersubscription Notice) by (ii) a fraction, the numerator of which is the number of shares of
Capital Stock owned by such Investor immediately before consummation of the Proposed Key Holder
Transfer (including any shares that such Investor has agreed to purchase pursuant to the Secondary
Refusal Right, the Tertiary Refusal Right or any

5

 

Undersubscription Notice) and the denominator of
which is the total number of shares of Capital Stock
owned, in the aggregate, by all Investors exercising the Right of Co-Sale immediately prior to
the consummation of the Proposed Key Holder Transfer (including any shares that all Investors have
collectively agreed to purchase pursuant to the Secondary Refusal Right, the Tertiary Refusal Right
or any Undersubscription Notice) plus the number of shares of Transfer Stock held by the selling
Key Holder.

To the extent one or more of the Investors exercise such right of participation in accordance with
the terms and conditions set forth herein, the number of shares of Transfer Stock that the selling
Key Holder may sell in the Proposed Key Holder Transfer shall be correspondingly reduced.

               (c) Delivery of Certificates. Each Investor shall effect its participation in the
Proposed Key Holder Transfer by delivering to the transferring Key Holder, no later than fifteen
(15) days after such Investor’s exercise of the Right of Co-Sale, one or more stock certificates,
properly endorsed for transfer to the Prospective Transferee, representing:

                    (i) the number of shares of Common Stock that such Investor elects to include in the Proposed
Key Holder Transfer; or

                    (ii) the number of shares of Class A Common Stock or Class B Common Stock that is at such time
convertible into the number of shares of Common Stock that such Investor elects to include in the
Proposed Key Holder Transfer; provided, however, that if the Prospective Transferee objects to the
delivery of Class A Common Stock or Class B Common Stock in lieu of Common Stock, such Investor
shall first convert the Class A Common Stock or Class B Common Stock into Common Stock and deliver
Common Stock as provided above. The Company agrees to make any such conversion concurrent with and
contingent upon the actual transfer of such shares to the Prospective Transferee.

               (d) Purchase Agreement. The parties hereby agree that the terms and conditions of any
sale pursuant to this Subsection 2.2 will be memorialized in, and governed by, a written
purchase and sale agreement with customary terms and provisions for such a transaction and the
parties further covenant and agree to enter into such an agreement as a condition precedent to any
sale or other transfer pursuant to this Subsection 2.2.

               (e) Deliveries. Each stock certificate an Investor delivers to the selling Key Holder
pursuant to Subsection 2.2(c) above will be transferred to the Prospective Transferee
against payment therefor in consummation of the sale of the Transfer Stock pursuant to the terms
and conditions specified in the Proposed Transfer Notice and the purchase and sale agreement, and
the selling Key Holder shall concurrently therewith remit or direct payment to each Investor the
portion of the sale proceeds to which such Investor is entitled by reason of its participation in
such sale. If any Prospective Transferee or Transferees refuse(s) to purchase securities subject
to the Right of Co-Sale from any Investor exercising its Right of Co-Sale hereunder, no Key Holder
may sell any Transfer Stock to such Prospective Transferee or Transferees unless and until,
simultaneously with such sale, such Key Holder purchases all securities subject to the Right of
Co-Sale from such Investor on the same terms and conditions (including the proposed purchase price)
as set forth in the Proposed Transfer Notice.

               (f) Additional Compliance. If any Proposed Key Holder Transfer is not consummated
within ninety (90) days after receipt of the Proposed Transfer Notice by the Company, the Key
Holders proposing the Proposed Key Holder Transfer may not sell any Transfer Stock unless they
again comply in full with each provision of this Section 2. The exercise or election not
to exercise any

6

 

right by any Investor hereunder shall not adversely affect its right to participate
in any other sales of Transfer Stock subject to this Subsection 2.2.

          2.3. Effect of Failure to Comply.

               (a) Transfer Void; Equitable Relief. Any Proposed Key Holder Transfer not made in
compliance with the requirements of this Agreement shall be null and void ab initio, shall not be
recorded on the books of the Company or its transfer agent and shall not be recognized by the
Company. Each party hereto acknowledges and agrees that any breach of this Agreement would result
in substantial harm to the other parties hereto for which monetary damages alone could not
adequately compensate. Therefore, the parties hereto unconditionally and irrevocably agree that
any non-breaching party hereto shall be entitled to seek protective orders, injunctive relief and
other remedies available at law or in equity (including, without limitation, seeking specific
performance or the rescission of purchases, sales and other transfers of Transfer Stock not made in
strict compliance with this Agreement).

               (b) Violation of First Refusal Right. If any Key Holder becomes obligated to sell any
Transfer Stock to the Company or any Investor under this Agreement and fails to deliver such
Transfer Stock in accordance with the terms of this Agreement, the Company and/or such Investor
may, at its option, in addition to all other remedies it may have, send to such Key Holder the
purchase price for such Transfer Stock as is herein specified and transfer to the name of the
Company or such Investor (or request that the Company effect such transfer in the name of an
Investor) on the Company’s books the certificate or certificates representing the Transfer Stock to
be sold.

               (c) Violation of Co-Sale Right. If any Key Holder purports to sell any Transfer Stock
in contravention of the Right of Co-Sale (a “Prohibited Transfer”), each Investor who desires to
exercise its Right of Co-Sale under Subsection 2.2 may, in addition to such remedies as may
be available by law, in equity or hereunder, require such Key Holder to purchase from such Investor
the type and number of shares of Capital Stock that such Investor would have been entitled to sell
to the Prospective Transferee under Subsection 2.2 had the Prohibited Transfer been
effected pursuant to and in compliance with the terms of Subsection 2.2. The sale will be
made on the same terms and subject to the same conditions as would have applied had the Key Holder
not made the Prohibited Transfer, except that the sale (including, without limitation, the delivery
of the purchase price) must be made within ninety (90) days after the Investor learns of the
Prohibited Transfer, as opposed to the timeframe proscribed in Subsection 2.2. Such Key
Holder shall also reimburse each Investor for any and all reasonable and documented out-of-pocket
fees and expenses, including reasonable legal fees and expenses, incurred pursuant to the exercise
or the attempted exercise of the Investor’s rights under Subsection 2.2.

     3. Exempt Transfers.

          3.1. Exempted Transfers. Notwithstanding the foregoing or anything to the contrary
herein, the provisions of Subsections 2.1 and 2.2 shall not apply: (a) in the case of an Entity Key
Holder, upon a transfer by such Entity Key Holder to its stockholders, members, partners,
Affiliates or other equity holders; (b) to a repurchase of Transfer Stock from a Key Holder by the
Company at a price no greater than that originally paid by such Key Holder for such Transfer Stock
and pursuant to an agreement containing vesting and/or repurchase provisions approved by a majority
of the Board of Directors; or (c) in the case of a Key Holder that is a natural person, upon a
transfer of Transfer Stock by such Key Holder made for bona fide estate planning purposes, either
during his or her lifetime or on death by will or intestacy to his or her spouse, child (natural or
adopted), or any other direct lineal descendant of such Key Holder (or his or her spouse) (all of
the foregoing collectively referred to as “family members”), or any other relative approved by
unanimous consent of the Board of Directors of the Company, or any custodian or trustee of any
trust, partnership or limited liability company for the benefit

7

 

of, or the ownership interests of
which are owned wholly by, such Key Holder or any such family members; provided that in the case of
clause (a) or (c), the Key Holder shall deliver prior written notice to the Investors of such gift
or transfer and such shares of Transfer Stock shall at all times remain subject to
the terms and restrictions set forth in this Agreement and such transferee shall, as a
condition to such issuance, deliver a counterpart signature page to this Agreement as confirmation
that such transferee shall be bound by all the terms and conditions of this Agreement as a Key
Holder (but only with respect to the securities so transferred to the transferee), including the
obligations of a Key Holder with respect to Proposed Key Holder Transfers of such Transfer Stock
pursuant to Section 2; and provided, further, in the case of any transfer pursuant to clause (a) or
(c) above, that such transfer is made pursuant to a transaction in which there is no consideration
actually paid for such transfer.

          3.2. Exempted Offerings. Notwithstanding the foregoing or anything to the contrary
herein, the provisions of Section 2 shall not apply to the sale of any Transfer Stock (a)
to the public in an offering pursuant to an effective registration statement under the Securities
Act of 1933, as amended, or (b) pursuant to a Deemed Liquidation Event (as defined in the Company’s
Certificate of Incorporation).

          3.3. Prohibited Transferees. Notwithstanding the foregoing, no Key Holder shall
transfer any Transfer Stock to (a) any entity which, in the determination of the Company’s Board of
Directors, directly or indirectly competes with the Company or PTTCH, or (b) any customer,
distributor or supplier of the Company, if the Company’s Board of Directors should determine that
such transfer would result in such customer, distributor or supplier receiving information that
would place the Company at a competitive disadvantage with respect to such customer, distributor or
supplier.

     4. Legend. Each certificate representing shares of Transfer Stock held by the Key
Holders or issued to any permitted transferee in connection with a transfer permitted by Subsection
3.1 hereof shall be endorsed with the following legend:

THE SALE, PLEDGE, HYPOTHECATION OR TRANSFER OF THE SECURITIES REPRESENTED BY THIS
CERTIFICATE IS SUBJECT TO, AND IN CERTAIN CASES PROHIBITED BY, THE TERMS AND
CONDITIONS OF A CERTAIN RIGHT OF FIRST REFUSAL AND CO-SALE AGREEMENT BY AND AMONG
THE STOCKHOLDER, THE CORPORATION AND CERTAIN OTHER HOLDERS OF STOCK OF THE
CORPORATION. COPIES OF SUCH AGREEMENT MAY BE OBTAINED UPON WRITTEN REQUEST TO THE
SECRETARY OF THE CORPORATION.

Each Key Holder agrees that the Company may instruct its transfer agent to impose transfer
restrictions on the shares represented by certificates bearing the legend referred to in this
Section 4 above to enforce the provisions of this Agreement, and the Company agrees to
promptly do so. The legend shall be removed upon termination of this Agreement at the request of
the holder.

     5. Lock-Up.

          5.1. Agreement to Lock-Up. Each Key Holder hereby agrees that it will not, without
the prior written consent of the managing underwriter, during the period commencing on the date of
the final prospectus relating to the Company’s initial public offering (the “IPO”) and ending on
the date specified by the Company and the managing underwriter (such period not to exceed one
hundred eighty (180) days, or such other period as may be requested by the Company or an
underwriter to accommodate regulatory restrictions on (1) the publication or other distribution of
research reports and (2) analyst recommendations and opinions, including, but not limited to, the
restrictions contained in FINRA Rule 2711(f)(4) or NYSE Rule 472(f)(4), or any successor provisions
or amendments thereto), (a) lend, offer,

8

 

pledge, sell, contract to sell, sell any option or
contract to purchase, purchase any option or contract to sell, grant any option, right or warrant
to purchase, or otherwise transfer or dispose of, directly or indirectly, any shares of Capital
Stock held immediately prior to the effectiveness of the registration
statement for the IPO or (b) enter into any swap or other arrangement that transfers to
another, in whole or in part, any of the economic consequences of ownership of the Capital Stock,
whether any such transaction described in clause (a) or (b) above is to be settled by delivery of
Capital Stock or other securities, in cash or otherwise. The foregoing provisions of this Section
5 shall not apply to the sale of any shares to an underwriter pursuant to an underwriting
agreement, and shall only be applicable to the Key Holders if all officers, directors and holders
of more than one percent (1%) of the outstanding Common Stock (after giving effect to the
conversion into Common Stock of all outstanding Class A Common Stock and Class B Common Stock)
enter into similar agreements. The underwriters in connection with the IPO are intended
third-party beneficiaries of this Section 5 and shall have the right, power and authority to
enforce the provisions hereof as though they were a party hereto. Each Key Holder further agrees
to execute such agreements as may be reasonably requested by the underwriters in the IPO that are
consistent with this Section 5 or that are necessary to give further effect thereto.

          5.2. Stop Transfer Instructions. In order to enforce the foregoing covenant, the
Company may impose stop-transfer instructions with respect to the shares of Capital Stock of each
Key Holder (and transferees and assignees thereof) until the end of such restricted period.

     6. Miscellaneous.

          6.1. Term. This Agreement shall automatically terminate upon the earlier of (a)
immediately prior but subject to the consummation of the Company’s IPO and (b) the consummation of
a Deemed Liquidation Event (as defined in the Company’s Certificate of Incorporation).

          6.2. Stock Split. All references to numbers of shares in this Agreement shall be
appropriately adjusted to reflect any stock dividend, split, combination or other recapitalization
affecting the Capital Stock occurring after the date of this Agreement.

          6.3. Ownership. Each Key Holder represents and warrants that such Key Holder is the
sole legal and beneficial owner of the shares of Transfer Stock subject to this Agreement and that
no other person or entity has any interest in such shares (other than a community property interest
as to which the holder thereof has acknowledged and agreed in writing to the restrictions and
obligations hereunder).

          6.4. Dispute Resolution. Any unresolved controversy or claim arising out of or
relating to this Agreement, except (i) as otherwise provided in this Agreement or (ii) any such
controversies or claims arising out of either party’s intellectual property rights for which a
provisional remedy or equitable relief is sought, shall be submitted to arbitration administered by
the American Arbitration Association (the “AAA”) in accordance with the International Commercial
Arbitration Rules then in effect. There shall be one (1) arbitrator mutually agreed upon by the
parties from the names of potential arbitrators proposed by the AAA. If no agreement on the sole
arbitrator can be reached within thirty (30) days after names of potential arbitrators have been
proposed by the AAA, then the AAA shall select the sole arbitrator, who shall have at least ten
(10) years experience in corporate finance transactions of the type provided for in this Agreement.
The arbitration shall take place in New York, New York, and any award shall be final and binding
and judgment thereon may be entered in any court having jurisdiction thereof. Each party will bear
its own costs in respect of any disputes arising under this Agreement. Each of the parties to this
Agreement consents to personal jurisdiction for any equitable action sought in the U.S. District
Court for the Southern District of New York or any court of the State of New York having subject
matter jurisdiction.

9

 

          6.5. Notices. All notices and other communications given or made pursuant to this
Agreement shall be in writing and shall be deemed effectively given upon the earlier of actual
receipt or:
(a) personal delivery to the party to be notified; (b) when sent, if sent by electronic mail
or facsimile during normal business hours of the recipient, and if not sent during normal business
hours, then on the recipient’s next business day, provided in either case, that the facsimile
transmission is promptly confirmed by telephone; (c) five (5) days after having been sent by
registered or certified mail, return receipt requested, postage prepaid; or (d) one (1) business
day after the business day of deposit with a nationally recognized overnight courier, freight
prepaid, specifying next business day delivery, with written verification of receipt. All
communications shall be sent to the respective parties at their address as set forth on
Schedule A or Schedule B hereto, or to such email address, facsimile number or
address as subsequently modified by written notice given in accordance with this Subsection
6.5. If notice is given to the Company, a copy shall also be sent to (a) DLA Piper LLP (US),
2000 University Avenue, East Palo Alto, California 94303-2215, USA, Attention: Curtis L. Mo,
facsimile: 650-687-1170, email: curtis.mo@dlapiper.com and (b) Byron S. Kalogerou, McDermott Will
& Emery, 28 State Street, 34th Floor, Boston, Massachusetts 02109-1775, USA, facsimile:
617-321-4605; email:bkalogerou@mwe.com. If notice is given to PTTCH, a copy shall also be given to
Allen & Overy (Thailand) Co., Ltd., 22nd Floor Sindhorn Building Tower III, 130-132 Wireless Road,
Lumpini Pathumwan, Bangkok 10330, Thailand, Attention: Arkrapol Pichedvanichok, facsimile: +66
(0)2 263 7699, email: arkrapol.pichedvanichok@allenovery.com.

          6.6. Entire Agreement. This Agreement (including the Exhibits and Schedules hereto),
the Company’s Amended and Restated Certificate of Incorporation and the other Transaction
Agreements (as defined in the Purchase Agreement) constitute the full and entire understanding and
agreement between the parties with respect to the subject matter hereof, and any other written or
oral agreement relating to the subject matter hereof existing between the parties are expressly
canceled.

          6.7. Delays or Omissions. No delay or omission to exercise any right, power or remedy
accruing to any party under this Agreement, upon any breach or default of any other party under
this Agreement, shall impair any such right, power or remedy of such non-breaching or
non-defaulting party nor shall it be construed to be a waiver of any such breach or default, or an
acquiescence therein, or of or in any similar breach or default thereafter occurring; nor shall any
waiver of any single breach or default be deemed a waiver of any other breach or default
theretofore or thereafter occurring. Any waiver, permit, consent or approval of any kind or
character on the part of any party of any breach or default under this Agreement, or any waiver on
the part of any party of any provisions or conditions of this Agreement, must be in writing and
shall be effective only to the extent specifically set forth in such writing. All remedies, either
under this Agreement or by law or otherwise afforded to any party, shall be cumulative and not
alternative.

          6.8. Amendment; Waiver and Termination. This Agreement may be amended, modified or
terminated (other than pursuant to Section 6.1 above) and the observance of any term hereof
may be waived (either generally or in a particular instance and either retroactively or
prospectively) only by a written instrument executed by (a) the Company, (b) the Key Holders
holding a majority of the shares of Transfer Stock then held by all of the Key Holders who are then
providing services to the Company as officers, employees or consultants and (c) the holders of at
least a majority of the shares of Common Stock issued or issuable upon conversion of the then
outstanding shares of Class A Common Stock and Class B Common Stock held by the Investors (voting
as a single class and on an as-converted basis). Any amendment, modification, termination or
waiver so effected shall be binding upon the Company, the Investors, the Key Holders and all of
their respective successors and permitted assigns whether or not such party, assignee or other
shareholder entered into or approved such amendment, modification, termination or waiver.
Notwithstanding the foregoing, (i) this Agreement may not be amended, modified or terminated and
the observance of any term hereunder may not be waived with

10

 

respect to any Investor or Key Holder
without the written consent of such Investor or Key Holder and (ii) the consent of the Key Holders
(other than the Investors) shall not be required for any amendment,
modification, termination or waiver if such amendment, modification, termination or waiver
does not apply to such Key Holders. The Company shall give prompt written notice of any amendment,
modification or termination hereof or waiver hereunder to any party hereto that did not consent in
writing to such amendment, modification, termination or waiver. No waivers of or exceptions to any
term, condition or provision of this Agreement, in any one or more instances, shall be deemed to
be, or construed as, a further or continuing waiver of any such term, condition or provision.

          6.9. Assignment of Rights.

               (a) The terms and conditions of this Agreement shall inure to the benefit of and be binding
upon the respective successors and permitted assigns of the parties. Nothing in this Agreement,
express or implied, is intended to confer upon any party other than the parties hereto or their
respective successors and permitted assigns any rights, remedies, obligations, or liabilities under
or by reason of this Agreement, except as expressly provided in this Agreement.

               (b) Any successor or permitted assignee of any Key Holder, including any Prospective
Transferee who purchases shares of Transfer Stock in accordance with the terms hereof, shall
deliver to the Company and the Investors, as a condition to any transfer or assignment, a
counterpart signature page hereto pursuant to which such successor or permitted assignee shall
confirm its agreement to be subject to and bound by all of the provisions set forth in this
Agreement that were applicable to the predecessor or assignor of such successor or permitted
assignee.

               (c) The rights of the Investors hereunder are not assignable without the Company’s written
consent (which shall not be unreasonably withheld, delayed or conditioned), except (i) by an
Investor to any Affiliate or (ii) to an assignee or transferee who acquires at least 100,000 shares
of Capital Stock (as adjusted for any stock combination, stock split, stock dividend,
recapitalization or other similar transaction), it being acknowledged and agreed that any such
assignment, including an assignment contemplated by the preceding clauses (i) or (ii) shall be
subject to and conditioned upon any such assignee’s delivery to the Company and the other Investors
of a counterpart signature page hereto pursuant to which such assignee shall confirm their
agreement to be subject to and bound by all of the provisions set forth in this Agreement that were
applicable to the assignor of such assignee.

               (d) Except in connection with an assignment by the Company by operation of law to the acquirer
of the Company, the rights and obligations of the Company hereunder may not be assigned under any
circumstances.

          6.10. Severability. The invalidity or unenforceability of any provision hereof shall
in no way affect the validity or enforceability of any other provision.

          6.11. Additional Investors. Notwithstanding anything to the contrary contained
herein, if the Company issues additional shares of Class A Common Stock or Class B Common Stock
after the date hereof, any acquirer of such shares of Class A Common Stock or Class B Common Stock
may become a party to this Agreement by executing and delivering an additional counterpart
signature page to this Agreement and thereafter shall be deemed an “Investor” for all purposes
hereunder. In such case, Schedule A hereto may be amended by the Company to add such person
without the consent of the other parties hereto.

          6.12. Governing Law. This Agreement and any controversy arising out of or relating to
this Agreement shall be governed by and construed in accordance with the internal laws of the State
of

11

 

New York, without regard to conflict of law principles that would result in the application of
any law other than the law of the State of New York.

          6.13. Titles and Subtitles. The titles and subtitles used in this Agreement are used
for convenience only and are not to be considered in construing or interpreting this Agreement.

          6.14. Counterparts. This Agreement may be executed in two or more counterparts, each
of which shall be deemed an original, but all of which together shall constitute one and the same
instrument. Counterparts may be delivered via facsimile, electronic mail (including pdf) or other
transmission method and any counterpart so delivered shall be deemed to have been duly and validly
delivered and be valid and effective for all purposes.

          6.15. Aggregation of Stock. All shares of Capital Stock held or acquired by
Affiliated entities or persons shall be aggregated together for the purpose of determining the
availability of any rights under this Agreement and such Affiliated persons may apportion such
rights among themselves in any manner they deem appropriate.

          6.16. Specific Performance. In addition to any and all other remedies that may be
available at law in the event of any breach of this Agreement, each Investor shall be entitled to
specific performance of the agreements and obligations of the Company and the Key Holders hereunder
and to such other injunction or other equitable relief as may be granted by a court of competent
jurisdiction.

          6.17. Additional Key Holders. In the event that after the date of this Agreement, the
Company issues shares of Common Stock, or options to purchase Common Stock, to any employee or
consultant, which shares or options would collectively constitute with respect to such employee or
consultant (taking into account all shares of Common Stock, options and other purchase rights held
by such employee or consultant) one percent (1%) or more of the Company’s then outstanding Common
Stock (treating for this purpose all shares of Common Stock issuable upon exercise of or conversion
of outstanding options, warrants or convertible securities, as if exercised or converted), the
Company shall, as a condition to such issuance, cause such employee or consultant to execute a
counterpart signature page hereto as a Key Holder, and such person shall thereby be bound by, and
subject to, all the terms and provisions of this Agreement applicable to a Key Holder. In such
case, Schedule B hereto may be amended by the Company to add such person without the
consent of the other parties hereto.

          6.18. Consent of Spouse. If any Key Holder is married on the date of this Agreement,
such Key Holder’s spouse shall execute and deliver to the Company a consent of spouse in the form
of Exhibit A hereto (“Consent of Spouse”), effective on the date hereof. Notwithstanding
the execution and delivery thereof, such consent shall not be deemed to confer or convey to the
spouse any rights in such Key Holder’s shares of Transfer Stock that do not otherwise exist by
operation of law or the agreement of the parties. If any Key Holder should marry or remarry
subsequent to the date of this Agreement, such Key Holder shall within thirty (30) days thereafter
obtain his/her new spouse’s acknowledgement of and consent to the existence and binding effect of
all restrictions contained in this Agreement by causing such spouse to execute and deliver a
Consent of Spouse acknowledging the restrictions and obligations contained in this Agreement and
agreeing and consenting to the same.

[Remainder of Page Intentionally Left Blank]

12

 

          IN WITNESS WHEREOF, the parties have executed this Right of First Refusal and Co-Sale
Agreement as of the date first written above.

	 	 	 	 	 
	 	COMPANY:

MYRIANT TECHNOLOGIES, INC.

 	 
	 	By:  	/s/ Stephen J. Gatto
 	 
	 	 	Stephen J. Gatto 	 
	 	 	Chairman and CEO

Address:

1 Pinehill Drive

Batterymarch Park II, Suite 301

Quincy, MA 02169-4801

Facsimile:  (617) 657-5210

Email:  sgatto@myriant.com 	 
	 

	 	 	 	 	 
	 	KEY HOLDERS:

NORWOOD LDK, LLC

 	 
	 	By:  	/s/ Stephen J. Gatto
 	 
	 	 	Name:  	Stephen J. Gatto 	 
	 	 	Title:  	President 	 
	 

	 	 	 	 	 
	 	ITERA ETHANOL, LLC

 	 
	 	By:  	/s/ Steven M. Sisselman
 	 
	 	 	Name:  	Steven M. Sisselman 	 
	 	 	Title:  	President 	 
	 

	 	 	 	 	 
	 	CAMULOS BIOENERGY PARTNERS LLC

 	 
	 	By:  	/s/ Michael Iuliano
 	 
	 	 	Name:  	Michael Iuliano 	 
	 	 	Title:  	Authorized Signatory 	 
	 

Signature Page to Myriant Technologies, Inc. Right of First Refusal and Co-Sale Agreement

 

 

	 	 	 	 	 
	 	INVESTORS AND KEY HOLDERS:

PTT CHEMICAL INTERNATIONAL PRIVATE LIMITED

 	 
	 	By:  	/s/ Narongsak Jivakanun
 	 
	 	 	Name:  	Narongsak Jivakanun 	 
	 	 	Title:  	Chief Executive Officer 	 
	 

	 	 	 	 	 
	 	GREEN CHEM HOLDINGS, LLC

 	 
	 	By:  	/s/ Steven M. Sisselman
 	 
	 	 	Name:  	Steven M. Sisselman 	 
	 	 	Title:  	President 	 
	 

	 	 	 	 	 
	 	GREEN CHEM SECOND EDITION, LLC

 	 
	 	By:  	/s/ Steven M. Sisselman
 	 
	 	 	Name:  	Steven M. Sisselman 	 
	 	 	Title:  	President 	 
	 

	 	 	 	 	 
	 	PLAINFIELD FINANCE II LLC

 	 
	 	By:  	/s/ Thomas X. Fritsch
 	 
	 	 	Name:  	Thomas X. Fritsch 	 
	 	 	Title:  	Co-General Counsel 	 
	 

	 	 	 	 	 
	 	PLAINFIELD DIRECT LLC

 	 
	 	By:  	/s/ Thomas X. Fritsch
 	 
	 	 	Name:  	Thomas X. Fritsch 	 
	 	 	Title:  	Co-General Counsel 	 
	 

	 	 	 	 	 
	 	STEPHEN J. GATTO

 	 
	 	/s/ Stephen J. Gatto
 	 
	 

Counterpart Signature Page to Myriant Technologies, Inc. Right of First Refusal and Co-Sale Agreement

 

 

SCHEDULE A

INVESTORS AND KEY HOLDERS

	 	 	 
	Name and Address	 	Number and Class of Shares Held
	PTT Chemical International Private Limited

391B Orchard Road, #15-05/08

Ngee Ann City Tower B

Singapore 238874

Attn: Mr. Narongsak Jivakanun

Fax: +65.6.734.3397

	 	11,214,953 Class A Common
	 
	 	 
	 
	 	 
	Plainfield Direct LLC and

Plainfield Finance II LLC

c/o Plainfield Asset Management, LLC

333 Ludlow Street

Stamford, CT 06902

Attn: James Healy

Jim.healy@pfam.com

Fax: 203.302.1779

	 	2,846,870 Class B Common

3,504,370 Common (including warrants exercisable for Common Stock)
	 
	 	 
	Green Chem Holdings, LLC

9995 Gate Parkway N., Suite 400

Jacksonville, FL 32246

	 	82,942 Class B Common

147,820 Common
	 
	 	 
	Green Chem Second Edition, LLC

9995 Gate Parkway N., Suite 400

Jacksonville, FL 32246

	 	64,617 Class B Common

182,621 warrants exercisable for Common Stock
	 
	 	 
	Stephen J. Gatto 

1 Pinehill Drive

Batterymark Park II, Suite 301

Quincy, MA 02169-5210 

sgatto@myriant.com

Fax: 617.657.5210

	 	50,476 Class B Common

134,089 Common (including warrants exercisable for Common Stock)

 

 

SCHEDULE B

KEY HOLDERS

	 	 	 
	Name and Address	 	Number of Shares Held
	Norwood LDK, LLC 

c/o Stephen Gatto

29 Royal Court

Norwood, MA 02062

	 	3,057,004 Common
	 
	 	 
	Itera Ethanol, LLC 

9995 Gate Parkway, Suite 400

Jacksonville, FL 32246

	 	373,784 Common (including warrants exercisable for Common Stock)
	 
	 	 
	Camulos BioEnergy Partners LLC

Three Landmark Square, 4th Floor

Stamford, CT 06901

	 	251,043 Common (including warrants exercisable for Common Stock)

 

 

EXHIBIT A

CONSENT OF SPOUSE

     I, [____________________], spouse of [______________], acknowledge that I have read the Right
of First Refusal and Co-Sale Agreement, dated as of January __, 2011, to which this Consent is
attached as Exhibit A (the “Agreement”), and that I know the contents of the Agreement. I
am aware that the Agreement contains provisions regarding certain rights to certain other holders
of Capital Stock of the Company upon a Proposed Key Holder Transfer of shares of Transfer Stock of
the Company which my spouse may own including any interest I might have therein.

     I hereby agree that my interest, if any, in any shares of Transfer Stock of the Company
subject to the Agreement shall be irrevocably bound by the Agreement and further understand and
agree that any community property interest I may have in such shares of Transfer Stock of the
Company shall be similarly bound by the Agreement.

     I am aware that the legal, financial and related matters contained in the Agreement are
complex and that I am free to seek independent professional guidance or counsel with respect to
this Consent. I have either sought such guidance or counsel or determined after reviewing the
Agreement carefully that I will waive such right.

Dated as of the [__] day of [__________, _____].

	 	 	 	 	 
	 	 	 
	 	
 	 
	 	Signature 	 

	 	 	 	 	 
	 	
 	 
	 	Print Name

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00190-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00190-of-00352.parquet"}]]